CYP Cynata Extends FUJIFILM Licence Option in GvHD 21/03/19 PRICE SENSITIVE Share CYP Trading Halt 19/03/19 PRICE SENSITIVE Share CYP Cynata Receives Favourable Advice on Planned CLI Trial 12/03/19 PRICE SENSITIVE Share CYP Appendix 4D & Half-Year Financial Statements 27/02/19 PRICE SENSITIVE Share CYP December 2018 Quarterly Report 29/01/19 PRICE SENSITIVE Share CYP CYP Receives Notice of Acceptance from Aust Patent Office 07/01/19 PRICE SENSITIVE Share CYP Cynata Completes Clinical Study Report in GvHD 18/12/18 PRICE SENSITIVE Share CYP NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs 13/12/18 PRICE SENSITIVE Share CYP Cynata Receives $1.3m R&D Tax Incentive Refund 19/11/18 PRICE SENSITIVE Share CYP CYP Receives Notice of Allowance from European Patent Office 07/11/18 PRICE SENSITIVE Share CYP September 2018 Quarterly Report 23/10/18 PRICE SENSITIVE Share CYP MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies 18/10/18 PRICE SENSITIVE Share CYP Cynata MSCs Ameliorate CRS in Preclinical Study 19/09/18 PRICE SENSITIVE Share CYP Cynata Advances to Official Meeting with Japanese PMDA 03/09/18 PRICE SENSITIVE Share CYP Cynata GvHD Trial Meets all Safety & Efficacy Endpoints 30/08/18 PRICE SENSITIVE Share CYP Appendix 4E & Financial Statements 22/08/18 PRICE SENSITIVE Share CYP Cymerus MSCs improve cardiac recovery in preclinical study 31/07/18 PRICE SENSITIVE Share CYP June 2018 Quarterly Report 11/07/18 PRICE SENSITIVE download Created with Sketch. 311.1KB Share CYP Cynata Enters Development Partnership with RCSI 02/07/18 PRICE SENSITIVE download Created with Sketch. 211.31KB Share CYP Product Development Program Update & Investor Presentation 26/06/18 PRICE SENSITIVE download Created with Sketch. 1.92MB Share CYP Positive 28-day Clinical Trial Data in Cohort B 21/06/18 PRICE SENSITIVE download Created with Sketch. 215.75KB Share CYP Research Collaboration with UNSW for Coronary Artery Disease 18/06/18 PRICE SENSITIVE download Created with Sketch. 170.96KB Share CYP Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD 12/06/18 PRICE SENSITIVE download Created with Sketch. 178.42KB Share CYP Cynata's MSCs Effective in Model of Diabetic Wounds 31/05/18 PRICE SENSITIVE download Created with Sketch. 185.44KB Share CYP $5.2m placement of shares to Fidelity International 30/05/18 PRICE SENSITIVE download Created with Sketch. 165.54KB Share CYP Trading Halt 28/05/18 PRICE SENSITIVE download Created with Sketch. 334.93KB Share CYP Enrolment Completed in Cynata's Phase 1 Clinical Trial 24/05/18 PRICE SENSITIVE download Created with Sketch. 205.81KB Share CYP Notice of Allowance from EPO for Patent Application 07/05/18 PRICE SENSITIVE Share CYP March 2018 Quarterly Report 27/04/18 PRICE SENSITIVE Share CYP CYP Completes Patent Application related to CAR-T Therapy 20/04/18 PRICE SENSITIVE Share CYP Further US Patent Granted for Cynata Cymerus Technology 11/04/18 PRICE SENSITIVE Share CYP FDA Grants Orphan Drug Designation to Cyanta for CYP-001 28/03/18 PRICE SENSITIVE Share CYP Response to ASX Aware Query 28/02/18 PRICE SENSITIVE Share CYP Appendix 4D & Half-Year Financial Statements 27/02/18 PRICE SENSITIVE Share CYP Excellent Data from Final Preliminary Evaluation Period 27/02/18 PRICE SENSITIVE Share CYP Cynata Engineered MSC Study Review Reveals Promising Results 05/02/18 PRICE SENSITIVE Share CYP December 2017 Quarterly Report 30/01/18 PRICE SENSITIVE Share CYP Cynata Treats First Patient in Cohort B 24/01/18 PRICE SENSITIVE Share CYP Cyanta & Celularity Inc Execute MOU 23/01/18 PRICE SENSITIVE Share CYP Encouraging Early Data-Cynata Clinical Trial Proceeds 22/01/18 PRICE SENSITIVE Share CYP Trading Halt 22/01/18 PRICE SENSITIVE Share CYP Cynata Receives $1.3m R&D Tax Incentive Refund 14/12/17 PRICE SENSITIVE Share CYP Final Preclinical Asthma Study Confirms Efficacy 11/12/17 PRICE SENSITIVE Share CYP United States Patent Allowance for Core Cynata Technology 07/12/17 PRICE SENSITIVE Share CYP Enrolment Completed in 1st Cohort of Cynata Clinical Trial 15/11/17 PRICE SENSITIVE Share CYP September 2017 Quarterly Report 27/10/17 PRICE SENSITIVE Share CYP Notice of Annual General Meeting/Proxy Form 09/10/17 PRICE SENSITIVE Share CYP Cynata to Increase Exposure in Japan 09/10/17 PRICE SENSITIVE Share CYP US Patent Granted for Cynata Cymerus Technology 27/09/17 PRICE SENSITIVE Share CYP Health Canada Meeting Advances CYP Global Development Plans 31/08/17 PRICE SENSITIVE Share CYP Appendix 4E & Financial Statements 24/08/17 PRICE SENSITIVE Share CYP Positive Data from CYP MSCs in 2nd Preclinical Asthma Study 23/08/17 PRICE SENSITIVE Share CYP June 2017 Quarterly Report 28/07/17 PRICE SENSITIVE Share CYP FDA Meeting Provides Clear Path for US Development Plans 05/07/17 PRICE SENSITIVE Share CYP Cynata Therapeutics GvHD Clinical Trial & Corporate Progress 27/06/17 PRICE SENSITIVE Share CYP CYP MSC Data in Asthma Model Published in Sceintific Journal 22/06/17 PRICE SENSITIVE Share CYP Cynata Files New Patent Application for Cymerus in Oncology 20/06/17 PRICE SENSITIVE Share CYP United States Patent for Core Cynata Technology 19/06/17 PRICE SENSITIVE Share CYP Treatment Commences in Cynata's World First Clinical Trial 16/05/17 PRICE SENSITIVE Share CYP Trading Halt 15/05/17 PRICE SENSITIVE Share CYP March 2017 Quarterly Report 26/04/17 PRICE SENSITIVE Share CYP Cynata Advances to Pre-IND Meeting with US FDA 19/04/17 PRICE SENSITIVE Share CYP CYP Files for New Patent for Oncology Applications 12/04/17 PRICE SENSITIVE Share CYP CYP in Collaboration on Acute Respiratory Distress Syndrome 11/04/17 PRICE SENSITIVE Share CYP Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation 31/03/17 PRICE SENSITIVE Share CYP CYP Advances Development of Cymerus for Treatment of Asthma 02/03/17 PRICE SENSITIVE Share CYP Appendix 4D & Half-Year Financial Statements 27/02/17 PRICE SENSITIVE Share CYP Final GvHD Preclinical Report Confirms Treatment Benefit 06/02/17 PRICE SENSITIVE Share CYP Positive Preliminary Data from Preclinical HeartAttack Study 02/02/17 PRICE SENSITIVE Share CYP Appendix 4C - quarterly 25/01/17 PRICE SENSITIVE Share CYP Cynata Successfully Completes Capital Raising 23/01/17 PRICE SENSITIVE Share CYP Trading Halt 19/01/17 PRICE SENSITIVE Share CYP Cynata & FUJIFILM Sign Strategic Partnership Agreement 19/01/17 PRICE SENSITIVE Share CYP Cynata's Clinical Study Approved in Austrralia 15/12/16 PRICE SENSITIVE Share CYP Cynata Receives NHS HRA Approval for Clinical Study 13/12/16 PRICE SENSITIVE Share CYP Cynata Files Further Patent Application 29/11/16 PRICE SENSITIVE Share CYP Cynata Receives $1.749m R&D Tax Incentive Refund 15/11/16 PRICE SENSITIVE Share CYP Activities Report & Appendix 4C-CYP.AX 31/10/16 PRICE SENSITIVE Share CYP Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX 17/10/16 PRICE SENSITIVE Share CYP UK Regulatory Authority Approves Cynata GvHD Clinical Trial-CYP.AX 19/09/16 PRICE SENSITIVE Share CYP Trading Halt-CYP.AX 19/09/16 PRICE SENSITIVE Share CYP CYP Determines not to proceed with Regience Investment Offer-CYP.AX 05/09/16 PRICE SENSITIVE Share CYP CYP & FUJIFILM Sign Non-Binding Terms Sheet-CYP.AX 05/09/16 PRICE SENSITIVE Share CYP Trading Halt-CYP.AX 02/09/16 PRICE SENSITIVE Share CYP Appendix 4E & Financial Statements-CYP.AX 19/08/16 PRICE SENSITIVE Share CYP Cynata Files Application to Commence Phase 1 Clinical Trial-CYP.AX 01/08/16 PRICE SENSITIVE Share CYP Activities Report & Appendix 4C-CYP.AX 29/07/16 PRICE SENSITIVE Share CYP Cynata Receives Investment Offer from Regience-CYP.AX 30/06/16 PRICE SENSITIVE Share CYP Cynata Prepares for Phase 1 Clinical Trial-CYP.AX 21/06/16 PRICE SENSITIVE Share CYP Cynata Enters Agreement with apceth GmbH & Co KG-CYP.AX 09/05/16 PRICE SENSITIVE Share CYP CYP Manufactures CT Product-Files Further Patent Application-CYP.AX 05/05/16 PRICE SENSITIVE Share CYP Decision to Grant Patent for Cymerus MSC Technology in Japan-CYP.AX 02/05/16 PRICE SENSITIVE Share CYP Cynata & Regience Extend Entitlement Period-CYP.AX 29/04/16 PRICE SENSITIVE Share CYP Quarterly Activities Report & Appendix 4C-CYP.AX 29/04/16 PRICE SENSITIVE Share CYP Compelling Results from Pre-Clinical Stem Cell Study in GvHD-CYP.AX 07/04/16 PRICE SENSITIVE Share CYP Cynata Enters Agreement for Strategic Alliance in Japan 03/03/16 PRICE SENSITIVE Share CYP Appendix 4D & Half-Year Financial Statements 26/02/16 PRICE SENSITIVE Share CYP Cynata Receives $930k R&D Tax Incentive Refund 16/02/16 PRICE SENSITIVE Share CYP Quarterly Activities Report & Appendix 4C 29/01/16 PRICE SENSITIVE Share CYP CYP Receives Favourable Advice from UK Regulatory Authority 28/01/16 PRICE SENSITIVE Share
21.5¢
(20min delay)
